Predicting The User Fee Reauthorization Schedule
PDUFA and GDUFA negotiations are expected to begin first, as they usually take the longest to complete, and will be followed by BsUFA talks.
You may also be interested in...
Both sides want enhancements to deal with growth in cell and gene therapy, as well as work on regulatory decision tools and finance issues.
Talks between US FDA and industry to extend the generic drug and prescription drug user fee programs may last into 2021.
Multiple stakeholders call for CBER to receive more prescription drug user fee funds amid growing cell and gene therapy popularity.